Mefenamic acid treatment to ward follicles development and progesterone level

In: Journal of Physics: Conference Series · 2020 · vol. 1569(3) , pp. 032065 · doi:10.1088/1742-6596/1569/3/032065 · W3044672886
article OA: diamond CC0

Abstract

Abstract Mefenamic acid is anti-inflammation non-steroid, which can hamper prostaglandin synthesis in the body tissue by hampering the siklooxigen enzyme. The purpose of this research is to find out the influence of Mefenamic acid toward the follicles development and progesterone level. This research is an experimental laboratory method. The subject of the research divided into five groups randomly selected and have been homogenized — one group as a control group and others as an experimental group with various dosages of Mefenamic acid treatment. The data is analyzed using a one-way Anova test. The results of this research are confirmed the significant difference of Grafian follicles, yellowish corpus luteum and progesterone level as the influence of Mefenamic acid. While there was no significant difference in tertiary follicles development. The decrease of corpus luteum is caused by Mephenamic acid activity to hamper the prostaglandin synthesis in the body tissue by hampering the siklooxigen enzyme. The prostaglandin can make follicles swelling and cause follicles fracture and make ovulation. The granulosis cell will make corpus luteum, which secreted progesterone hormone. Mefenamic acid was proven to avoid ovulation that blocked the formation of yellowish corpus luteum resulting in decreased blood progesterone level.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (12)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK